Leukapheresis Device Market Research Reveals Path To $1.01 Billion By 2030

The leukapheresis device market is poised for significant expansion in the coming years, driven by technological advancements and rising demand in medical and research fields. As healthcare evolves towards more personalized and efficient treatments, this market is set to witness robust growth fueled by innovation and strategic partnerships.

Projected Market Size and Growth Rate of the Leukapheresis Device Market
The leukapheresis device market is forecasted to reach a value of $1.01 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.4%. This upward trajectory is supported by the increasing demand for portable leukapheresis systems, the integration of artificial intelligence and automation into device design, expanding biopharmaceutical research activities, regulatory approvals for cutting-edge apheresis tools, and rising investments in precision medicine. Key trends expected to influence the market include the development of personalized leukapheresis therapies, adoption of minimally invasive techniques, growth in portable and point-of-care devices, incorporation of real-time monitoring features, and improvements in automation and workflow efficiency.

Download a free sample of the leukapheresis device market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25807&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Key Factors Driving Expansion in the Leukapheresis Device Market
One important driver of market growth is the push for portable leukapheresis devices, which offer flexibility and accessibility in clinical settings. These systems support patient mobility and make treatments more convenient, which is especially valuable in outpatient care or remote locations.
In addition, the surge in biopharmaceutical research is propelling demand for advanced leukapheresis technologies. Enhanced device capabilities help support complex procedures such as stem cell collection, immune therapies, and other cell-based treatments, fueling market expansion.

Top Companies Leading the Leukapheresis Device Industry
The leukapheresis device market features a number of prominent players, including Fresenius SE and Co. KGaA, Asahi Kasei Medical Co. Ltd, Baxter International Inc., Grifols S.A., TERUMO BCT INC., Kaneka Corporation, Nikkiso Co. Ltd, Haemonetics Corporation, Miltenyi Biotec GmbH, Macopharma, B. Braun Melsungen AG, Kawasumi Laboratories Inc., Beijing Zksk Technology Co. Ltd, Puriblood Medical Co. Ltd, Fresenius Kabi AG, JMS Co. Ltd, HemaCare Corporation, Medica Group PLC, LivaNova PLC, Cytiva, BioSafe Group SA, and Terumo Corporation.
A notable collaboration occurred in November 2025 when Terumo Blood and Cell Technologies (Terumo BCT) partnered with Switzerland-based Santersus AG to develop an innovative therapeutic apheresis technology aimed at improving treatment outcomes for sepsis patients. This partnership combines Santersus' NucleoCapture blood purification device with Terumo BCT's Spectra OptiaTM Apheresis System to selectively remove neutrophil extracellular traps (NETs) from the blood, potentially lowering sepsis mortality rates and enhancing patient care.

View the full leukapheresis device market report:
https://www.thebusinessresearchcompany.com/report/leukapheresis-device-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends and Innovations Influencing the Leukapheresis Device Market
Manufacturers are increasingly focusing on regional production capabilities to improve supply chain efficiency and ensure timely delivery of high-quality devices. Establishing local manufacturing hubs also reduces dependence on imports and makes advanced leukapheresis systems more affordable and accessible worldwide.
For example, in November 2024, Terumo Blood and Cell Technologies teamed up with its Chinese subsidiary, Terumo Medical Products (Hangzhou) Co., Ltd., to commence localized manufacturing in Hangzhou, China. This venture focuses on producing key leukapheresis products such as the Trima Accel Automated Blood Collection System and the Spectra Optia Apheresis System, both widely used in China for therapeutic apheresis, stem cell collection, and blood component separation.

Understanding the Main Segments Within the Global Leukapheresis Device Market
The global leukapheresis device market is segmented by device type, components, and end users.
By device type, the market includes therapeutic leukapheresis, cytapheresis, stem cell collection, research applications, leukapheresis columns and cell separators, leukapheresis disposables, and apheresis devices.
Component segments cover leukapheresis machines, blood collection sets, medical consumables, and filters.
End-user categories consist of hospitals, academic research institutions, pharmaceutical and biotechnology companies, blood component providers, and blood centers.
Further sub-segmentation within therapeutic leukapheresis includes systems for leukemia treatment, sepsis management, and autoimmune disease care. Cytapheresis subcategories include plateletpheresis devices, lymphapheresis units, and erythrocytapheresis systems. Stem cell collection segments encompass peripheral blood stem cell (PBSC) collection devices, umbilical cord blood collection systems, and bone marrow stem cell apheresis systems. Research applications range from cell separation platforms for R&D to clinical trial devices and academic laboratory equipment. Leukapheresis columns and cell separators are divided into adsorption columns, membrane-based systems, and centrifugal separators. Disposable items include tubing sets, needles, catheters, and collection bags. Apheresis devices are classified into continuous flow machines, portable/mobile units, and intermittent flow systems.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.